This document focuses on a specific set of critical terms that are frequently used in protocols for pharmacogenetic testing and that are relevant to define appropriate levels of protection for the privacy of the subjects when describing how the results and samples will be used in clinical trials.

Keywords: Pharmacogenomics, pharmacogenetics, clinical trials

Current effective version

Share this page